Trevi Therapeutics, INC. (TRVI) — SC 13D/A Filings

All SC 13D/A filings from Trevi Therapeutics, INC.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (2)

NEA 16 Amends Trevi Therapeutics Stake Filing — Nov 8, 2024 Risk: medium
New Enterprise Associates 16, L.P. (NEA 16) filed an amendment to its Schedule 13D on November 8, 2024, regarding its holdings in Trevi Therapeutics, Inc. The f
NEA 16 Group Amends Trevi Therapeutics Stake to 5.8% — May 21, 2024 Risk: medium
New Enterprise Associates 16, L.P. (NEA 16) and its affiliates have amended their Schedule 13D filing for Trevi Therapeutics, Inc. (TRVI) as of May 21, 2024. Th

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX